UB Paderborn / Katalog / Suche / in CDI

Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis

Journal of acquired immune deficiency syndromes (1999), 2009-09, Vol.52 (1), p.70

2009

Volltextzugriff (PDF)

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Nature (London), 1993-03, Vol.362 (6418), p.355-358

1993

Volltextzugriff (PDF)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy

BMC infectious diseases, 2011-11, Vol.11 (1), p.310-310, Article 310

2011

Volltextzugriff (PDF)

HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy

Current HIV research, 2010-06, Vol.8 (4), p.336

2010

Volltextzugriff (PDF)

Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals

Journal of Virology, 2001-11, Vol.75 (22), p.10843-10855

2001

Volltextzugriff (PDF)

Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals

The Journal of immunology (1950), 2005-03, Vol.174 (5), p.2900-2909

2005

Volltextzugriff (PDF)

Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma

Cancer, 2003-12, Vol.98 (11), p.2440-2446

2003

Volltextzugriff (PDF)

Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy

AIDS research and human retroviruses, 2015-03, Vol.31 (3), p.282

2015

Volltextzugriff (PDF)

Intercellular adhesion molecules (ICAM)‐1 ICAM‐2 and ICAM‐3 function as counter‐receptors for lymphocyte function‐associated molecule 1 in human immunodeficiency virus‐mediated syncytia formation

European journal of immunology, 1994-09, Vol.24 (9), p.2191-2195

1994

Volltextzugriff (PDF)

Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients

Journal of acquired immune deficiency syndromes (1999), 2005-04, Vol.38 (4), p.407

2005

Volltextzugriff (PDF)

Molecular analysis of hepatitis B virus

BMC infectious diseases, 2011-11, Vol.11, p.310

2011

Volltextzugriff (PDF)

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

Journal of acquired immune deficiency syndromes (1999), 2006-01, Vol.41 (1), p.23

2006

Volltextzugriff (PDF)

Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication

AIDS (London), 2006-08, Vol.20 (13), p.1713-1720

2006

Volltextzugriff (PDF)

Specific Changes in the Posttranslational Regulation of Nucleolin in Lymphocytes from Patients Infected with Human Immunodeficiency Virus

The Journal of infectious diseases, 2003-11, Vol.188 (10), p.1483-1491

2003

Volltextzugriff (PDF)

Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)

Current medical research and opinion, 2004-07, Vol.20 (7), p.1103-1114

2004

Volltextzugriff (PDF)

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation

AIDS (London), 2002-03, Vol.16 (4), p.619-624

2002

Volltextzugriff (PDF)

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART

Journal of medical virology, 2008-10, Vol.80 (10), p.1695-1706

2008

Volltextzugriff (PDF)

Durability and tolerability of long-term nevirapine-based HAART

Le infezioni in medicina, 2010-03, Vol.18 (1), p.20

2010

Volltextzugriff (PDF)

Durability and tolerability of long-term nevirapine-based HAART

Le infezioni in medicina, 2010-03, Vol.18 (1), p.20-26

2010

Volltextzugriff (PDF)

Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution

Journal of virology, 1999-05, Vol.73 (5), p.3764-3777

1999

Volltextzugriff (PDF)

Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo

Journal of Virology, 1996-11, Vol.70 (11), p.7603-7613

1996

Volltextzugriff (PDF)

Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients

AIDS (London), 1999-07, Vol.13 (10), p.1159-1164

1999

Volltextzugriff (PDF)

Highly active antiretroviral therapy induces specific changes in effector and central memory T cell subpopulations

AIDS (London), 2001-09, Vol.15 (14), p.1887-1890

2001

Volltextzugriff (PDF)

Highly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations

AIDS (London), 2001-09, Vol.15 (14), p.1887-1890

2001

Volltextzugriff (PDF)

Loss of CD127 Expression Defines an Expansion of Effector CD8 super(+) T Cells in HIV-Infected Individuals

The Journal of immunology (1950), 2005-03, Vol.174 (5), p.2900-2909

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy

HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy

Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals

Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals

Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma

Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy

Intercellular adhesion molecules (ICAM)‐1 ICAM‐2 and ICAM‐3 function as counter‐receptors for lymphocyte function‐associated molecule 1 in human immunodeficiency virus‐mediated syncytia formation

Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients

Molecular analysis of hepatitis B virus

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication

Specific Changes in the Posttranslational Regulation of Nucleolin in Lymphocytes from Patients Infected with Human Immunodeficiency Virus

Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART

Durability and tolerability of long-term nevirapine-based HAART

Durability and tolerability of long-term nevirapine-based HAART

Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution

Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo

Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients

Highly active antiretroviral therapy induces specific changes in effector and central memory T cell subpopulations

Highly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations

Loss of CD127 Expression Defines an Expansion of Effector CD8 super(+) T Cells in HIV-Infected Individuals

Suchergebnisse filtern